Background Image
Table of Contents Table of Contents
Previous Page  37 / 64 Next Page
Information
Show Menu
Previous Page 37 / 64 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 5, September/October 2020

AFRICA

257

Clinical spectrum and prevalence of congenital heart

disease in children in Botswana

Tiny Mazhani, Andrew P Steenhoff, Endale Tefera, Thuso David, Zaakir Patel, Warona Sethomo, Marek

Smieja, Loeto Mazhani

Abstract

Background:

Reliable data on congenital heart disease (CHD)

from diverse settings is important both for planning health

systems in each country and to elucidate possible aetiologies

of CHD in different settings. There is a lack of data on the

clinical spectrum and prevalence of CHD in Botswana. The

aim of this study was to describe the clinical spectrum and

prevalence of CHD in Botswana.

Methods:

This was a retrospective, descriptive, cross-sectional

study of all children from birth to 15 years who had had

an echocardiogram performed as an in- or out-patient at

Princess Marina Hospital (PMH) between 1 January 2010

and 31 December 2012.

Results:

Of 377 enrollees, 140 (40%) had normal echocardio-

graphs, 170 (45%) had CHD, and 57 (15%) had an acquired

lesion. In the CHD patients, median age was 0.9 years (Q1:

0.2, Q3: 4.1) and 85 (50%) were male. Ventricular septal

defect (VSD) (29%), patent ductus arteriosus (18%), atrio-

ventricular septal defect (AVSD) (10%) and tetralogy of

Fallot (TOF) (6%) were the predominant pathologies. VSD

was the most common acyanotic lesion and TOF the most

common cyanotic lesion. The estimated prevalence of CHD

was between 2.8 and 4.95 per 1 000 live births.

Conclusions:

The clinical spectrum of CHD in Botswana is

similar to that observed in other African countries and in the

Western world, with VSD the most common acyanotic lesion

and TOF the most common cyanotic lesion. The prevalence

of CHD was 2.8–4.95 per 1 000 live births, in keeping with

other settings. This is the first study to describe CHD in

Botswana, and it aimed to stimulate subsequent studies in

this field.

Keywords:

paediatric, cardiology, acquired heart disease, Africa

Submitted 5/5/19, accepted 1/6/20

Published online 22/6/20

Cardiovasc J Afr

2020;

31

: 257–261

www.cvja.co.za

DOI: 10.5830/CVJA-2020-021

Congenital heart disease (CHD) is defined as a gross structural

abnormality of the heart or intrathoracic great vessels.

1

Although

this abnormality is present at birth, it may initially be clinically

silent and present with symptoms only later in life.

2

The

prevalence and pattern of CHD varies within and between

countries.

3

Reported estimates vary widely and there may be

differences between low-, middle- and high-income countries.

Reliable data on CHD from diverse settings are important for

both planning health systems in each country and to elucidate

possible aetiologies of CHD in different settings.

4

In Botswana, as is the case in many low- and middle-income

countries (LMIC), the clinical spectrum and prevalence of CHD

is unknown as there are no published data on the epidemiology

of CHD. The majority of Botswana’s population receives clinical

care from the government-funded public health system. As in

many LMICs, Botswana’s public health system faces challenges

both in diagnosing and managing CHD. However, there is

some in-country expertise, including echocardiography, to both

diagnose and medically manage CHD. Additionally, for those

patients with a correctable lesion, Botswana’s middle-income

status enables Batswana citizens to be referred to other countries

for cardiac intervention and surgery. In this article we seek to

begin to address the paucity of data on CHD in Botswana. Our

objective was to describe the clinical spectrum and prevalence of

CHD in Botswana.

Methods

This was a retrospective, descriptive, cross-sectional study of

all children who had had an echocardiogram performed as an

in- or out-patient at Princess Marina Hospital (PMH). The

study period was from 1 January 2010 to 31 December 2012.

The project was reviewed and approved by ethics boards at

the Botswana Ministry of Health, PMH and the University of

Botswana.

PMH is a 525-bed tertiary hospital located in Gaborone,

Botswana’s capital city. PMH is the main tertiary referral centre

for district hospitals and clinics located in southern Botswana.

For paediatric cardiology during the study period, the PMH

paediatric cardiac clinic was the only referral centre for the

entire country. The paediatric cardiac clinic saw out-patients

three times a week and did in-patient consultations daily. It was

Department of Paediatric and Adolescent Health, Faculty

of Medicine, University of Botswana, Gaborone, Botswana

Tiny Mazhani, MMed, MD,

tinym106@yahoo.com

Andrew P Steenhoff, MD

Endale Tefera, MD

Thuso David, MD

Zaakir Patel, MD

Warona Sethomo, MD

Loeto Mazhani, MD

Children’s Hospital of Philadelphia and University of

Pennsylvania, Philadelphia, USA

Andrew P Steenhoff, MD

Department of Paediatrics, Princess Marina Hospital,

Gaborone, Botswana

Loeto Mazhani, MD

McMaster University, Hamilton, Ontario, Canada

Marek Smieja, MD, PhD